Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alliances symbols : SNY save search
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
merck potential
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
collaboration trial sanofi
Adimab Provides 2023 Update on Clinical Pipeline
Published: 2024-01-09 (Crawled : 15:30) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
IGMS | News | $7.65 -5.9% 40K
|
Health Technology
|
| O: -0.9%
H: 13.74%
C: 6.01%
update pipeline
Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer
Published: 2023-12-19 (Crawled : 11:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
cancer collaboration diagnostics agreement
AnHeart Therapeutics and Innovent Announce China’s NMPA Has Accepted a New Drug Application for Taletrectinib (ROS1 Inhibitor)
Published: 2023-11-22 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.74%
H: 0.71%
C: 0.71%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
INCY | $52.46 -0.49% 330K
|
Health Technology
|
| O: 0.56%
H: 1.06%
C: -0.24%
drug application therapeutics
BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics
Published: 2023-10-10 (Crawled : 11:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
drug collaboration sanofi
Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal
Published: 2023-09-19 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: -1.16%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.09%
H: 1.16%
C: 1.16%
sanofi
Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers
Published: 2023-07-12 (Crawled : 12:20) - biospace.com/
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.29%
H: 0.49%
C: 0.26%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
hope beacon education novartis trial
Moderna Signs $1B Deal to Develop mRNA Drugs for China
Published: 2023-07-05 (Crawled : 22:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -1.61%
H: 0.06%
C: -0.51%
mrna deal china
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care
Published: 2023-05-01 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
health acquisition care trials collaboration sanofi
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
Published: 2023-04-25 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: -1.65%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: 0.0%
ALXO | $15.99 -0.56% 260K
|
Commercial Services
|
| O: -0.37%
H: 12.84%
C: 0.73%
collaboration trial sarclisa sanofi
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
Published: 2023-04-11 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
Janssen Returns Phase I NASH Candidate to Arrowhead
Published: 2023-02-15 (Crawled : 17:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
candidate nash
BioSpace's Top Biopharma M&A Candidates for 2023
Published: 2022-12-22 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -2.17%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
biopharma
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
Published: 2022-12-22 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -2.17%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -12.41%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
BNTX | $86.085 -0.37% 160K
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.5%
covid-19 pharma vaccine china
Sanofi Deepens NK Cell Therapy Partnership with Innate Pharma
Published: 2022-12-19 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.54%
H: 0.51%
C: -0.25%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
partnership pharma therapy sanofi
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Eosinophilic Esophagitis
Published: 2022-12-16 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -1.49%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
REGN | $898.42 -0.31% 75K
|
Health Technology
|
| O: -1.3%
H: 1.48%
C: 0.19%
dupixent treatment chmp approval
First Protein Degrader Tested Outside Oncology Yields Promising Results
Published: 2022-12-14 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 2.88%
H: 0.48%
C: -0.21%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
results
Horizon Therapeutics Becomes Target of Acquisition By Pharma Giants
Published: 2022-11-30 (Crawled : 17:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -2.65%
H: 0.0%
C: 0.0%
acquisition pharma therapeutics
AstraZeneca and C4X Discovery Ink $402M COPD Collaboration
Published: 2022-11-28 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.57%
H: 1.04%
C: -1.87%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
collaboration
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0504 35.12% 300M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.